<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">CNS Neurosci Ther</journal-id>
<journal-id journal-id-type="iso-abbrev">CNS Neurosci Ther</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1755-5949</journal-id>
<journal-id journal-id-type="publisher-id">CNS</journal-id>
<journal-title-group>
<journal-title>CNS Neuroscience &amp; Therapeutics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1755-5930</issn>
<issn pub-type="epub">1755-5949</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29529357</article-id>
<article-id pub-id-type="pmc">6490029</article-id>
<article-id pub-id-type="doi">10.1111/cns.12840</article-id>
<article-id pub-id-type="publisher-id">CNS12840</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Review Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Review Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Dysregulation of mi<styled-content style="fixed-case">RNA</styled-content> and its potential therapeutic application in schizophrenia</article-title>
<alt-title alt-title-type="left-running-head">CAO and ZHEN</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="cns12840-cr-0001">
<name>
<surname>Cao</surname>
<given-names>Ting</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8525-1428</contrib-id>
<xref ref-type="aff" rid="cns12840-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="cns12840-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="cns12840-cr-0002">
<name>
<surname>Zhen</surname>
<given-names>Xue‐Chu</given-names>
</name>
<address>
<email>zhenxuechu@suda.edu.cn</email>
</address>
<xref ref-type="aff" rid="cns12840-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="cns12840-aff-0002">
<sup>2</sup>
</xref>
</contrib>
</contrib-group>
<aff id="cns12840-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Jiangsu Key Laboratory of Neuropsychiatric Diseases</named-content>
<named-content content-type="organisation-division">College of Pharmaceutical Sciences</named-content>
<institution>Soochow University</institution>
<named-content content-type="city">Suzhou</named-content>
<country country="CN">China</country>
</aff>
<aff id="cns12840-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">The Collaborative Innovation Center for Brain Science</named-content>
<institution>Soochow University</institution>
<named-content content-type="city">Suzhou</named-content>
<country country="CN">China</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Xue‐Chu Zhen, Jiangsu Key Laboratory of Neuropsychiatric Diseases, College of Pharmaceutical Sciences, Soochow University, Suzhou, China.<break></break>
Email: <email>zhenxuechu@suda.edu.cn</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>12</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<month>7</month>
<year>2018</year>
</pub-date>
<volume>24</volume>
<issue>7</issue>
<issue-id pub-id-type="doi">10.1111/cns.2018.24.issue-7</issue-id>
<issue-title>Special Issue on Emerging and evolving concepts in the pathobiology and treatment of psychosis</issue-title>
<fpage>586</fpage>
<lpage>597</lpage>
<history>
<date date-type="received">
<day>18</day>
<month>12</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>12</day>
<month>2</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>2</month>
<year>2018</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2018 John Wiley & Sons Ltd <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2018 John Wiley &amp; Sons Ltd</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:href="file:CNS-24-586.pdf" xlink:type="simple"></self-uri>
<abstract id="cns12840-abs-0001">
<title>Summary</title>
<p>Although it is generally believed that genetic and developmental factors play critical roles in pathogenesis of schizophrenia, however, the precise etiological mechanism of schizophrenia remains largely unknown. Over past decades, mi<styled-content style="fixed-case">RNA</styled-content>s have emerged as an essential post‐transcriptional regulator in gene expression regulation. The importance of mi<styled-content style="fixed-case">RNA</styled-content> in brain development and neuroplasticity has been well‐established. Abnormal expression and dysfunction of mi<styled-content style="fixed-case">RNA</styled-content>s are known to involve in the pathophysiology of many neuropsychiatric diseases including schizophrenia. In this review, we summarized the recent findings in the schizophrenia‐associated dysregulation of mi<styled-content style="fixed-case">RNA</styled-content> and functional roles in the development and pathogenesis of schizophrenia. We also discussed the potential therapeutic implications of mi<styled-content style="fixed-case">RNA</styled-content> regulation in the illness.</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="cns12840-kwd-0001">mi<styled-content style="fixed-case">RNA</styled-content>s</kwd>
<kwd id="cns12840-kwd-0002">neuroplasticity</kwd>
<kwd id="cns12840-kwd-0003">schizophrenia</kwd>
<kwd id="cns12840-kwd-0004">single nucleotide polymorphism</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>National Natural Science Foundation of China</funding-source>
<award-id>81372688</award-id>
<award-id>81373382</award-id>
<award-id>81773702</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="1"></table-count>
<page-count count="12"></page-count>
<word-count count="9777"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>cns12840</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>July 2018</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.2.1 mode:remove_FC converted:02.05.2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="cns12840-cit-1001" publication-type="journal">
<string-name>
<surname>Cao</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Zhen</surname>
<given-names>X‐C</given-names>
</string-name>. <article-title>Dysregulation of miRNA and its potential therapeutic application in schizophrenia</article-title>. <source xml:lang="en"/>CNS Neurosci Ther. <year>2018</year>;<volume>24</volume>:<fpage>586</fpage>–<lpage>597</lpage>. <pub-id pub-id-type="doi">10.1111/cns.12840</pub-id>
<pub-id pub-id-type="pmid">29529357</pub-id></mixed-citation>
</p>
</notes>
</front>
</article>
</pmc-articleset>